ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Zafgen Inc

Zafgen Inc (ZFGN)

0.99
0.00
(0.00%)
Closed September 23 4:00PM
0.99
0.00
( 0.00% )
Pre Market: 8:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.99
Bid
0.9801
Ask
0.99
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.99
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
43,906,000
Dividend Yield
-
PE Ratio
-1.18
Earnings Per Share (EPS)
-0.84
Revenue
-
Net Profit
-36.95M

About Zafgen Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-

ZFGN Latest News

Zafgen Reports Fourth Quarter and Full Year 2019 Financial Results

Zafgen and Chondrial Therapeutics previously announced a definitive merger agreement Merger creates clinical-stage company focused on the development of novel protein replacement therapies for...

Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement

Creates clinical-stage company focused on the development of novel protein replacement therapies for rare diseases Chondrial Therapeutics’ lead asset, CTI-1601, currently being evaluated in Phase...

Zafgen Reports Third Quarter 2019 Financial Results

Evaluation of strategic alternatives ongoing BOSTON, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN) today reported its third quarter 2019 financial results. In September 2019...

Zafgen to Explore Strategic Alternatives

BOSTON, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel...

Zafgen Reports Second Quarter 2019 Operating and Financial Results

Agreement reached with U.S. FDA on in vivo animal study design and protocol to translate work from novel in vitro assays and establish relevant safety margins Topline data from the in vivo study...

Zafgen to Present at the Wedbush PacGrow Healthcare Conference

BOSTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel...

Zafgen Announces Agreement with U.S. Food and Drug Administration on New Nonclinical Study Design for ZGN-1061

Alignment reached on in vivo animal study design and protocol to translate work from novel in vitro assays and establish relevant safety margins Topline data from the in vivo study expected by...

Zafgen to Present at the JMP Securities Life Sciences Conference

BOSTON, June 13, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel...

Zafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Association's 79th Scientific S...

Delivered comprehensive oral presentation on both cohorts of the clinical trial, including previously announced results for second cohort evaluating doses up to 1.8 mg Company also presented data...

Zafgen Announces Regulatory Update on ZGN-1061

Received FDA Type A meeting minutes related to previously announced clinical hold FDA acknowledged newly developed in vitro assays of human plasma coagulation and tissue factor expression...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MSSMaison Solutions Inc
$ 1.49
(108.39%)
8.95M
SEELSeelos Therapeutics Inc
$ 0.3345
(76.05%)
5.29M
TRNRInteractive Strength Inc
$ 0.3676
(55.56%)
39.07M
HSCSHeart Test Laboratories Inc
$ 4.30
(46.26%)
4.32M
GBNYGenerations Bancorp NY Inc
$ 15.38
(39.82%)
137.79k
BIVIBioVie Inc
$ 1.27
(-54.64%)
228.35k
GHSIGuardion Health Sciences Inc
$ 5.60
(-46.77%)
7.8k
TOIIWOncology Institute Inc
$ 0.014
(-25.13%)
23k
FRESFresh2 Group Ltd
$ 1.45
(-20.33%)
24.78k
LNWLight and Wonder Inc
$ 95.25
(-15.47%)
3.67k
MLGOMicroAlgo Inc
$ 0.2372
(19.56%)
39.85M
TRNRInteractive Strength Inc
$ 0.37
(56.58%)
39.13M
SLXNSilexion Therapeutics Corporation
$ 1.045
(35.68%)
10.62M
MSSMaison Solutions Inc
$ 1.49
(108.39%)
8.96M
SEELSeelos Therapeutics Inc
$ 0.3325
(75.00%)
5.36M

Discussion

View Full Feed
Jake731 Jake731 4 minutes ago
Good morning all.








TPTW……!!!!!!!!!!!
TPTW
ChangnoiPlaza ChangnoiPlaza 5 minutes ago
Arguing with stupid people is like playing chess with a pigeon. No matter how good you are at chess, the pigeon will knock over all the pieces, poop on the board and strut around like it won.
COOP
RIGATONI RIGATONI 5 minutes ago
$1.78 ~Rig
Sir Pumpernickel Sir Pumpernickel 5 minutes ago
Thank you Ex !!
NWBO
azhector31 azhector31 6 minutes ago
pathetic post
ICTY
cottonisking cottonisking 6 minutes ago
The Alternative Outcome was removed. Deutsch Bank supported the alternative outcome. Maybe CTs' Holders? A mystery now...

1 The tier Y distribution applies for the next layer
2 of funds, if available , as your Lordship can see. And
3 there are at this point, and this fee
LEHNQ
cottonisking cottonisking 6 minutes ago
The Alternative Outcome was removed. Deutsch Bank supported the alternative outcome. Maybe CTs' Holders? A mystery now...

1 The tier Y distribution applies for the next layer
2 of funds, if available , as your Lordship can see. And
3 there are at this point, and this fee
LEHNQ
Kutz71 Kutz71 6 minutes ago
No idea… on Stocktwits someone got a response on 9/18 from Greg stating “just finalizing what has been communicated already”. Wish more people would reach out.
GRLT
JonDoe1 JonDoe1 6 minutes ago
If he's been issued over 2 billion shares and not sold he's required by law to be listed as a 5% shareholder. Since he's not listed as a 5% shareholder he sold. Not sure why you can't figure that out.
AABB
JTORENCE JTORENCE 6 minutes ago
That's when Leo had everybody fooled just as he did with the 4 million$$ he just scammed out of us.
IPIX
t1215s t1215s 6 minutes ago
Picks I posted “(RIGHT OR WRONG)” I’ve also posted “PROFIT ISSSS PROFIT more is better) I also sold @ 50.00 (58% +/-)
and theirs nothing wrong with taking something off the table, , now when people refuse to believe something why keep pissing into the wind for so many years unless there’s
COOP
exwannabe exwannabe 7 minutes ago
It is hard to believe England's MHRA will approve DCVAX and the FDA will not.
Fixed it for you.
NWBO
jxyzobrien jxyzobrien 8 minutes ago
what is low volume and no energy
its balancing and now in day 3 (elliot wave calls this wave 4 used to kill time and build energy for accumulation or distribution)
at top of balance
so i expect a return to balance low
now if balance area high is support ready to advance
MonkDomain94 MonkDomain94 8 minutes ago
HeartCore Enterprises Inc. (NASDAQ: HTCR) | A Rising Player in Digital Transformation

https://www.tradingview.com/x/cQUPgXwX/

HeartCore Enterprises Inc. (HTCR) is a global digital transformation company offering businesses cutting-edge software and services to help them
HTCR
RIGATONI RIGATONI 8 minutes ago
$1.70 clearing ~Rig
joe botts joe botts 8 minutes ago
Its nothing other then REVOKED. The posts are actually hysterical.
Moonboy1 Moonboy1 8 minutes ago
I sold at 7am in the $17.60s. I would have sold yesterday in the $18 range but couldn't because I was out of day trades. Bought most at $5-$6 so I'm not losing that profit. I will watch for a while but this is completely out of control for a stock that was at $3 just a few weeks ago. No company gr
LASE
MADDSTACKER MADDSTACKER 9 minutes ago
Great news :)
VFF
PRCubaDog PRCubaDog 9 minutes ago
This is pumper boys way of saying he lied and hasn't bought a share in years. 🤣🤣🤣 BK IMMINENT!
INNDD
fuagf fuagf 9 minutes ago
You're right, two good posts by you questioning OMOLIVE's position, the first here ..

I don't understand what you are trying to prove.

2) Gradual increase in the age of eligibility for full benefits to age 66 in 2009 and to age 67 in 2027. The earnings test will also b
jackson73 jackson73 9 minutes ago
SEEL .41 ww on news out...

https://www.prnewswire.com/news-releases/seelos-therapeutics-announces-the-signing-of-a-material-transfer-agreement-with-us-army-medical-materiel-development-activity-usammda-to-evaluate-sls-002-for-treatment-of-ptsd-302256228.html
RIGATONI RIGATONI 10 minutes ago
$6.68 with a new high on news...


Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy

https://finance.yahoo.com/news/capricor-therapeutics-ann
CAPR
JohnSmith4 JohnSmith4 10 minutes ago
BAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHHAHAHAHAHAHAHAHAHAHHAHA
TSOI
subslover subslover 10 minutes ago
I told that dog over 1 month ago to call a plumber. He got upset with at that statement so Roto-Rooter never showed
MLGO

Your Recent History

Delayed Upgrade Clock